Lupin To Market Novartis' Inhaler Under Loftair Brand Name

New Delhi: Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India. As part of the pact, Lupin would be using its own specialty field force to promote Loftair inhaler. Novartis will continue to market Indacaterol/ Glycopyrronium 110mcg/ 50mcg inhaler under its brand name Se...